PARP1 and breast cancer: To confirm inhibition of PARP and to rule out in vivo vs. in vitro activity discrepancies, i.e. differences of PARP expression in cells vs. an isolated PARP enzyme, we analysed accumulation of DNA damage in a human breast cancer cell line upon treatment with Compound 1 and Vatalanib.